Study of fibrinopeptide A, fibrin monomer and fibrin degradation products in non-insulin dependent diabetes mellitus
Journal of the Egyptian Society of Endocrinology, Metabolism and Diabetes [The]. 1990; 22 (1): 153-171
em Inglês
| IMEMR
| ID: emr-145602
ABSTRACT
The study was carried out on 20 non-insulin dependent diabetics and 10 healthy adult control subjects. The work aimed at estimation of fibrinopeptide A [FPA], fibrin monomer [FM] and fibrin degradation products [FDP] in non-insulin dependent diabetic patients with and without vascular complications, in addition to euglobulin clot lysis time [EGCLT], blood sugar, serum triglycerides, serum cholesterol, HDL-cholesterol and LDL-cholesterol. Serum fibrinopeptide-A [FPA] level was elevated in diabetics with vascular complications, reflecting augmented thrombin activity. EGCLT showed significant prolongation in diabetics with vascular complications. Pathological levels of FDP were detected in three diabetic patients [30%] with vascular complications. The significance of these findings were then analyzed and discussed
Buscar no Google
Índice:
IMEMR (Mediterrâneo Oriental)
Assunto principal:
Triglicerídeos
/
Produtos de Degradação da Fibrina e do Fibrinogênio
/
Fibrinopeptídeo A
/
Soroglobulinas
/
Colesterol
Limite:
Feminino
/
Humanos
/
Masculino
Idioma:
Inglês
Revista:
J. Egypt. Soc. Endocrinol. Metab. Diabetes
Ano de publicação:
1990
Similares
MEDLINE
...
LILACS
LIS